MEDIA RELEASE
MicroBioGen and Novonesis Expand Partnership into Biochemicals
Expanded partnership highlights versatility of MicroBioGen’s yeast technology
28 March 2025, Sydney, Australia: MicroBioGen, an Australian-based yeast biotech company and provider of ‘Yeast Innovation as a Service,’ has expanded its existing long-term global bioethanol partnership with biosolutions leader Novonesis into biochemicals amongst other products. The expanded partnership leverages MicroBioGen’s portfolio of yeast strains and Novonesis’ R&D and commercialization expertise to provide yeast innovations for the global bioethanol market.
Geoffrey Bell, MicroBioGen CEO and Co-Founder, commented: “MicroBioGen is thrilled to be expanding our partnership with Novonesis. Both organisations are committed to delivering innovative solutions, as demonstrated by our 11-year partnership in the bioethanol industry.”
“The expanded partnership demonstrates the extensive potential of our combined innovation. MicroBioGen’s platform of yeast chassis are redefining what can be achieved in both GM and Non-GM applications, from ‘drop-in’ products to emerging industries such as biochemicals. We look forward to extending our innovative solutions to new sectors and building on the success of our collaboration with Novonesis on Innova® yeast products in the bioethanol industry.”
“At Novonesis, we are dedicated to delivering exceptional value to our customers by harnessing the power of cutting-edge yeast technology,” states Katy Cagle, Head of Bioenergy Business Unit. “Our collaboration with MicroBioGen exemplifies our shared commitment to innovation and excellence, setting new industry standards through our Innova® platform. As we expand our partnership, we are focused on developing next-generation biosolutions that meet the industry’s future needs and create lasting impact.”
END
For additional information, images or to arrange an interview, please contact:
An Grobler, MicroBioGen Communications Manager | [email protected]
Available for interview: MicroBioGen CEO and co-founder, Geoff Bell
About MicroBioGen: MicroBioGen is an Australian based biotechnology company with global success in improving the industrial capabilities of Saccharomyces cerevisiae. This yeast is the world’s most widely used microorganism, underpinning around US$2 trillion in products, from biofuels and pharmaceuticals to mycoproteins for food and feed.
With a proprietary platform technology and library of elite yeast genetics, developed over 20 years, MicroBioGen delivers ‘Yeast Innovation as a Service’ to industry leaders globally.
Demonstrated through MicroBioGen’s biofuels partnership with Novonesis and co-developing the Innova® yeast series which delivers unparalleled industrial performance, MicroBioGen is the collaborator of choice for yeast biotechnology, with opportunities in existing and emerging industries, ranging from optimising yeast for baking, sustainable feed and energy to food applications. For more information, visit www.microbiogen.com